(91 days)
MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images.
It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.
Mammo Workstation is designed to give easy and economic access to and display of multimodality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.
Mammo Workstation supports teleradiology and teleconferencing providing access to multimodality softcopy images and structured reports in multiple locations within and outside the hospital.
Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.
Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography.
All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading.
The Mammo Workstation is a medical image review workstation software for diagnostic and screening mammography.
Mammoworkstation has the capability to review Digital Breast Tomosynthesis (DBT) images that are compatible with DICOM Breast Tomosynthesis Image Storage.
It is a software product.
The provided document is a 510(k) Premarket Notification Submission for the GE Healthcare MammoWorkstation. It describes the device's intended use and substantial equivalence to predicate devices. However, the document explicitly states that "The subject of this premarket submission, MammoWorkstation, did not require clinical studies to support substantial equivalence."
Therefore, the information required to populate the acceptance criteria and study details for device performance is not available in the provided text. The submission relies on non-clinical tests (risk analysis, requirements reviews, design reviews, various levels of testing like unit, integration, performance, safety, and simulated use testing) to demonstrate substantial equivalence to its predicate devices.
Here's a summary of what can be extracted based on the prompt's requirements, with explicit notation of what is not provided:
1. Table of Acceptance Criteria and Reported Device Performance:
| Acceptance Criteria | Reported Device Performance |
|---|---|
| Safety and Effectiveness through Substantial Equivalence(Implied criteria: Device attributes and performance are similar to legally marketed predicate devices) | "GE Healthcare considers the Mammo Workstation to be as safe, as effective, and performance is substantially equivalent to the predicate device(s)." |
| Compliance with Voluntary Standards(Implied criteria: Adherence to relevant industry and regulatory standards) | "The Mammo Workstation and its applications comply with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission." |
| Quality Assurance Measures Applied(Process-based criteria for development and testing) | Demonstrated through: Risk Analysis, Requirements Reviews, Design Reviews, Testing on unit level (Module verification), Integration testing (System verification), Performance testing (Verification), Safety testing (Verification), Simulated use testing (Validation). |
| Image Compatibility for Digital Breast Tomosynthesis (DBT)(Criteria: Ability to review and process DBT images) | "Mammoworkstation has the capability to review Digital Breast Tomosynthesis (DBT) images that are compatible with DICOM Breast Tomosynthesis Image Storage." |
| Image Quality Conformance(Criteria: All images conform to regulatory and quality guidelines) | "All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines." |
| Modalities Certification for Soft-copy Reading(Criteria: Hardware supporting the workstation is certified for diagnostic reading) | "All modalities must be certified for soft-copy reading." |
| Display Monitor Approval for Digital Mammography (Criteria: Monitors used for primary diagnosis must be approved) | "Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography." |
2. Sample size used for the test set and the data provenance:
- Not provided. The document states that "MammoWorkstation, did not require clinical studies." Therefore, there is no test set with clinical data to report. Non-clinical testing was performed (e.g., unit, integration, performance, safety, simulated use testing) but details on specific test sets (e.g., number of images, type of data) are not included.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable/Not provided. As no clinical studies were performed requiring a test set with ground truth established by experts.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- Not applicable/Not provided. No clinical studies or test sets requiring expert adjudication were performed.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not done. The document explicitly states "did not require clinical studies." This type of study would be a clinical study. The device is a "Medical imaging software" that is a "workstation" for review and analysis, not an AI CAD system claiming to improve human reader performance directly.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
- Not applicable/Not provided. Since this is a workstation software and not an AI algorithm for autonomous detection/diagnosis, a standalone performance study in that context would not be relevant. The submission focuses on the functionality and safety of the workstation itself.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- Not applicable/Not provided. No clinical ground truth was established as no clinical studies were deemed necessary.
8. The sample size for the training set:
- Not applicable/Not provided. As no AI/CAD algorithm (that would require a training set) is the primary subject of clinical evaluation here. The device is a workstation.
9. How the ground truth for the training set was established:
- Not applicable/Not provided. No training set for an AI algorithm was used for clinical evaluation.
{0}------------------------------------------------
K.123575
Image /page/0/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized, cursive font, enclosed within a circular shape. There are decorative swirls or flourishes around the outer edge of the circle, adding a touch of elegance to the design. The logo is presented in black and white.
GE Healthcare
510(k) Premarket Notification Submission
FEB 1 9 2013
Section 5: 510(k) Summary
MammoWorkstation
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized, cursive font, enclosed within a circle. There are three small, decorative swirls or flourishes placed around the outer edge of the circle, evenly spaced. The logo is black and white.
GE Healthcare
510(k) Premarket Notification Submission
510(k) Summary
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date: | 13 November 2012 |
|---|---|
| Submitter: | GE Healthcare, (Image Diagnost International GmbH)Oskar-Schlemmer-Str. 11;80807 München, Germany |
| Primary Contact Person: | Mounir Zaouali, RACRegulatory Affairs LeaderGE Healthcare, (GE Medical Systems, SCS)283 RUE DE LA MINIERE78530 BUC - FRANCEPhone: + 33 1 30 70 45 39Fax: + 33 1 30 70 41 40Mounir.Zaouali@ge.com |
| Secondary ContactPerson: | Steven Kachelmeyer, RACRegulatory Affairs Director - X-rayGE HealthcarePhone: 262-548-2432Fax: 262-997-1080Steven.Kachelmeyer@med.ge.com |
| Device Trade Name: | Mammo Workstation |
| Common/Usual Name: | Medical imaging software |
| Classification Names: | Picture archiving and communication systemClass II CFR 892.2050 System, Image Processing,Radiological, |
| Product Code: | LLZ |
| Predicate Device(s): | Mammo Workstation (version 3.3.2) K081630Hologic SecurView DX K103385 |
5-2
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "G" and "E" intertwined within a circle. There are three small white swirls around the circle, one at the top and two at the bottom.
GE Healthcare
510(k) Premarket Notification Submission
| Device Description: | The Mammo Workstation is a medical image reviewworkstation software for diagnostic and screeningmammography.Mammoworkstation has the capability to review DigitalBreast Tomosynthesis (DBT) images that are compatiblewith DICOM Breast Tomosynthesis Image Storage.It is a software product. |
|---|---|
| Intended Use: | Mammo Workstation is designed to assist radiologistsin conducting primary diagnostic review for diagnosticand screening mammography through flexible andinteractive manipulation of multi-modality softcopyimages.It provides image review, manipulation, analysis, post-processing and printing capabilities that support imagemanagement display needs in the medical environment.Mammo Workstation is designed to give easy andeconomic access to and display of multi-modalitysoftcopy images, structured reports, and CAD resultsthrough interfaces to various image storage devicesusing DICOM or similar interface standards. Itsupports creation of structured reports according to theDICOM breast imaging report templates.Mammo Workstation supports teleradiology andteleconferencing providing access to multi-modalitysoftcopy images and structured reports in multiplelocations within and outside the hospital.Lossy compressed mammographic images must not beused for primary diagnostic interpretation unlessapproved for use in digital mammography.Display monitors used for primary diagnosticinterpretation of mammographic images must beapproved for use in digital mammography." |
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized, cursive font, enclosed within a circular frame. The frame has decorative swirls or flourishes at four points around the circle, giving it a distinctive and recognizable appearance. The logo is in black and white.
·
・
.
:
.
1
| All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading. | |
|---|---|
| Technology: | MammoWorkstation is software product. It is designed to run on a standard workstation with a minimum of three monitors, one control monitor and high-resolution monitor (s) that are cleared for mammography. review |
| It runs on Windows Operating System. | |
| Determination ofSubstantial Equivalence: | Summary of Non-Clinical Tests:The Mammo Workstation and its applications comply with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance measures were applied to the development of the system:Risk AnalysisRequirements ReviewsDesign ReviewsTesting on unit level (Module verification)Integration testing (System verification)Performance testing (Verification)Safety testing (Verification)Simulated use testing (Validation)Summary of Clinical Tests:The subject of this premarket submission, MammoWorkstation, did not require clinical studies to support substantial equivalence. |
| Conclusion: | GE Healthcare considers the Mammo Workstation to be as safe, as effective, and performance is substantially equivalent to the predicate device(s). |
,
·
5-4
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a stylized eagle with three lines representing its wings, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged in a circular fashion around the eagle. The text is in all caps and is smaller than the eagle symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 19, 2013
Image Diagnost International GmbH c/o Mounir Zaouali GE Healthcare, (GE Medical Systems, SCS) 283 RUE DE LA MINIERE BUC FRANCE 78530
Re: K123575
Trade/Device Name: MammoWorkstation Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: November 15, 2012 Received: November 20, 2012
Dear Mr. Zaouali:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{5}------------------------------------------------
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
FDA
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Indications for Use Form
510(k) Number (if known): K123575
Device Name: Mammo Workstation
Indications For Use:
MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images.
It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.
Mammo Workstation is designed to give easy and economic access to and display of multimodality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.
Mammo Workstation supports teleradiology and teleconferencing providing access to multimodality softcopy images and structured reports in multiple locations within and outside the hospital.
Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.
Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography.
All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading.
| Prescription Use_X____________________________________________________________________________________________________________________________________________________________ | AND/OR | Over-The-Counter Use |
|---|---|---|
| (Part 21 CFR 801 Subpart D) | (Part 21 CFR 801 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of (CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR) Sin Vis Jan 2
Division Sign-Off Office of In Vitro Diagnostics and Radiological Health
510(k) K123575
Page 1 of
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).